Chronic treatment of (R)-α-lipoic acid reduces blood glucose and lipid levels in high-fat diet and low-dose streptozotocin-induced metabolic syndrome and type 2 diabetes in Sprague-Dawley rats

Pharmacology Research and Perspectives

Volumn 5, Issue 3, 2017, Pages

  Ghelani, Hardik ^a,b   Razmovski Naumovski, Valentina ^a,b,c   Nammi, Srinivas ^a,b  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b WESTERN SYDNEY UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

(R) lipoic acid; high fat diet; hyperglycemia; hyperlipidemia; metabolic syndrome; streptozotocin; type 2 diabetes

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STREPTOZOCIN; THIOCTIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; BIOCHEMICAL ANALYSIS; BLOOD ANALYSIS; BODY WEIGHT; CONTROLLED STUDY; CORONARY RISK; DIABETES CONTROL; INSULIN SENSITIVITY; LIPID DIET; LOW DRUG DOSE; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POST HOC ANALYSIS; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

EID: 85026614338     PISSN: None     EISSN: 20521707     Source Type: Journal    
DOI: 10.1002/prp2.306     Document Type: Article

References (83)

1. Ada N (2004). Prevention or delay of type 2 diabetes. Diabetes Care 27: S47–S54.
2. Alberti KG, Zimmet P, Shaw J (2006). Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23: 469–480.
3. Amom Z, Zakaria Z, Mohamed J, Azlan A, Bahari H, Taufik Hidayat Baharuldin M, et al. (2008). Lipid lowering effect of antioxidant alpha-lipoic Acid in experimental atherosclerosis. J Clin Biochem Nutr 43: 88–94.
4. Anuradha B, Varalakshmi P (1999). Protective role of DL-alpha-lipoic acid against mercury-induced neural lipid peroxidation. Pharmacol Res 39: 67–80.
5. Arambasic J, Mihailovic M, Uskokovic A, Dinic S, Grdovic N, Markovic J, et al. (2013). Alpha-lipoic acid upregulates antioxidant enzyme gene expression and enzymatic activity in diabetic rat kidneys through an O-GlcNAc-dependent mechanism. Eur J Nutr 52: 1461–1473.
6. Aude YW, Mego P, Mehta JL (2004). Metabolic syndrome: dietary interventions. Curr Opin Cardiol 19: 473–479.
7. Biewenga GP, Haenen GR, Bast A (1997). The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 29: 315–331.
8. Black K, Qu X, Seale JP, Donnelly R (1998). Metabolic effects of thioctic acid in rodent models of insulin resistance and diabetes. Clin Exp Pharmacol Physiol 25: 712–714.
9. Brown MS, Goldstein JL (1986). A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34–47.
10. Budin SB, Kee KP, Eng MYS, Osman K, Bakar MA, Mohamed J (2007). Alpha lipoic acid prevents pancreatic islet cells damage and dyslipidemia in streptozotocin-induced diabetic rats. MJMS 14: 47–53.
11. Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Scholmerich J, et al. (2006). Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 36: 485–501.
12. Buettner R, Scholmerich J, Bollheimer LC (2007). High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15: 798–808.
13. Butler JA, Hagen TM, Moreau R (2009). Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. Arch Biochem Biophys 485: 63–71.
14. Carrier B, Wen S, Zigouras S, Browne RW, Li Z, Patel MS, et al. (2014). Alpha-lipoic acid reduces ldl-particle number and PCSK9 concentrations in high-fat fed obese zucker rats. PLoS ONE 9: e90863.
15. Castro MC, Massa ML, Schinella G, Gagliardino JJ, Francini F (2013). Lipoic acid prevents liver metabolic changes induced by administration of a fructose-rich diet. Biochim Biophys Acta 1830: 2226–2232.
16. Chen XS, Liu H, Ji AM, Yang YL, Yao YF, Sun L, et al. (2009). Effects of sustained-release alpha-lipoic acid tablet on blood lipid, blood sugar and insulin in hyperlipidemic New Zealand rabbits. Nan Fang Yi Ke Da Xue Xue Bao 29: 704–706.
17. Chen WL, Kang CH, Wang SG, Lee HM (2012). α-Lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase. Diabetologia 55: 1824–1835.
18. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. (2008). General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117: 743–753.
19. Davi G, Santilli F, Patrono C (2010). Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc Ther 28: 216–226.
20. Dinic S, Arambasic J, Mihailovic M, Uskokovic A, Grdovic N, Markovic J, et al. (2013). Decreased O-GlcNAcylation of the key proteins in kinase and redox signalling pathways is a novel mechanism of the beneficial effect of alpha-lipoic acid in diabetic liver. Br J Nutr 110: 401–412.
21. Edelman SV (1998). Type II diabetes mellitus. Adv Intern Med 43: 449–500.
22. Faust A, Burkart V, Ulrich H, Weischer CH, Kolb H (1994). Effect of lipoic acid on cyclophosphamide-induced diabetes and insulitis in non-obese diabetic mice. Int J Immunopharmacol 16: 61–66.
23. Feng B, Yan X-F, Xue J-L, Xu L, Wang H (2013). The protective effects of α-lipoic acid on kidneys in type 2 diabetic goto-kakisaki rats via reducing oxidative stress. Int J Mol Sci 14: 6746–6756.
24. Fernandez ML (2007). The metabolic syndrome. Nutr Rev 65: S30–34.
25. Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499–502.
26. Fröde TS, Medeiros YS (2008). Animal models to test drugs with potential antidiabetic activity. J Ethnopharmacol 115: 173–183.
27. Fujimoto WY (2000). The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am J Med 108: 9s–14s.
28. Gomes MB, Negrato CA (2014). Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. Diabetol Metab Syndr 6: 80.
29. Goraca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B (2011). Lipoic acid - biological activity and therapeutic potential. Pharmacol Rep 63: 849–858.
30. Grundy SM (2012). Pre-diabetes, metabolic syndrome and cardiovascular risk. Am Coll Cardiol 59: 635–643.
31. Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, et al. (2010). The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 95: 3347–3351.
32. Huong DT, Ide T (2008). Dietary lipoic acid-dependent changes in the activity and mRNA levels of hepatic lipogenic enzymes in rats. Br J Nutr 100: 79–87.
33. Jang A, Kim D, Sung KS, Jung S, Kim HJ, Jo C (2014). The effect of dietary alpha-lipoic acid, betaine, l-carnitine, and swimming on the obesity of mice induced by a high-fat diet. Food Funct 5: 1966–1974.
34. Jin HY, Lee KA, Wu JZ, Baek HS, Park TS (2014). The neuroprotective benefit from pioglitazone (PIO) addition on the alpha lipoic acid (ALA)-based treatment in experimental diabetic rats. Endocrine 47: 772–782.
35. Jones PJ (1997). Regulation of cholesterol biosynthesis by diet in humans. Am J Clin Nutr 66: 438–446.
36. Kahn SE, Hull RL, Utzschneider KM (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840–846.
37. Khamaisi M, Potashnik R, Barnea E, Peleg N, Tritschler H, Wessel K, et al. (1995). Effect of lipoic acid on glucose homeostasis and muscle glucose transporters in diabetic rats. Pharmacol Res 31: 85.
38. Khamaisi M, Rudich A, Potashnik R, Tritschler HJ, Gutman A, Bashan N (1999). Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats. Metabolism 48: 504–510.
39. Khanna S, Roy S, Packer L, Sen CK (1999). Cytokine-induced glucose uptake in skeletal muscle: redox regulation and the role of alpha-lipoic acid. Am J Physiol 276: R1327–1333.
40. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, et al. (2001). The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 50: 1464–1471.
41. Kwiterovich PO Jr (2000). The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. Am J Cardiol 86: 51–101.
42. Lee WJ, Song KH, Koh EH, Won JC, Kim HS, Park HS, et al. (2005). Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem Biophys Res Commun 332: 885–891.
43. Lee JE, C-o Yi, Jeon BT, Shin HJ, Kim SK, Jung TS, et al. (2012). Alpha-lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats. Cardiovasc Diabetol 11: 111.
44. Lender D, Sysko SK (2006). The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care. Pharmacotherapy 26: 3s–12s.
45. Lenzen S (2008). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51: 216–226.
46. Marangon K, Devaraj S, Tirosh O, Packer L, Jialal I (1999). Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress. Free Radic Biol Med 27: 1114–1121.
47. Maritim AC, Sanders RA, Watkins JB 3rd (2003). Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 14: 288–294.
48. McNeilly AM, Davison GW, Murphy MH, Nadeem N, Trinick T, Duly E, et al. (2011). Effect of alpha-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance. Lipids Health Dis 10: 217.
49. Miao Y, Ren J, Jiang L, Liu J, Jiang B, Zhang X (2013). Alpha-Lipoic acid attenuates obesity-associated hippocampal neuroinflammation and increases the levels of brain-derived neurotrophic factor in ovariectomized rats fed a high-fat diet. Int J Mol Med 32: 1179–1186.
50. Midaoui AE, Talbot S, Lahjouji K, Dias JP, Fantus IG, Couture R (2015). Effects of alpha-lipoic acid on oxidative stress and kinin receptor expression in obese zucker diabetic fatty rats. J Diabetes Metab 6: 1–7.
51. Moller DE (2001). New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414: 821–827.
52. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, et al. (1995). Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18: 1160–1167.
53. Nair AB, Jacob S (2016). A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7: 27–31.
54. Niemeijer-Kanters SD, Banga JD, Erkelens DW (2001). Lipid-lowering therapy in diabetes mellitus. Neth J Med 58: 214–222.
55. Obrosova I, Cao X, Greene DA, Stevens MJ (1998). Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-alpha-lipoic acid. Diabetologia 41: 1442–1450.
56. Packer L, Witt EH, Tritschler HJ (1995). alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227–250.
57. Raal FJ (2009). Pathogenesis and management of the dyslipidemia of the metabolic syndrome. Metab Syndr Relat Disord 7: 83–88.
58. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, et al. (2000). A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49: 1390–1394.
59. Reuter TY (2007). Diet-induced models for obesity and type 2 diabetes. Drug Discovery Today: Disease Models 4: 3–8.
60. Rideout TC, Carrier B, Wen S, Raslawsky A, Browne RW, Harding SV (2016). Complementary Cholesterol-Lowering Response of a Phytosterol/alpha-Lipoic Acid Combination in Obese Zucker Rats. J Diet Suppl 13: 283–299.
61. Rochette L, Ghibu S, Muresan A, Vergely C (2015). Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can J Physiol Pharmacol 93: 1021–1027.
62. Salama RH (2011). Hypoglycemic effect of lipoic acid, carnitine and Nigella sativa in diabetic rat model. Int J Health Sci (Qassim) 5: 126–134.
63. Sena CM, Nunes E, Louro T, Proenca T, Fernandes R, Boarder MR, et al. (2008). Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. Br J Pharmacol 153: 894–906.
64. Seo EY, Ha AW, Kim WK (2012). Alpha-Lipoic acid reduced weight gain and improved the lipid profile in rats fed with high fat diet. Nutr Res Pract 6: 195–200.
65. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM (2009). Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 1790: 1149–1160.
66. Shen QW, Zhu MJ, Tong J, Ren J, Du M (2007). Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by alpha-lipoic acid in C2C12 myotubes. Am J Physiol Cell Physiol 293: C1395–1403.
67. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F (2008). The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6: 299–304.
68. Skovsø S (2014). Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Investig 5: 349–358.
69. Srinivasan K, Ramarao P (2007). Animal models in type 2 diabetes research: an overview. Indian J Med Res 125: 451–472.
70. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P (2005). Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol Res 52: 313–320.
71. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321: 405–412.
72. Streeper RS, Henriksen EJ, Jacob S, Hokama JY, Fogt DL, Tritschler HJ (1997). Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am J Physiol 273: E185–191.
73. Subramaniam S, Subramaniam R, Rajapandian S, Uthrapathi S, Gnanamanickam VR, Dubey GP (2011). Anti-Atherogenic Activity of Ethanolic Fraction of Terminalia arjuna Bark on Hypercholesterolemic Rabbits. Evid Based Complement Alternat Med 2011: 487916.
74. Sudheesh NP, Ajith TA, Janardhanan KK, Krishnan CV (2011). Palladium-alpha-lipoic acid complex attenuates alloxan-induced hyperglycemia and enhances the declined blood antioxidant status in diabetic rats. J Diabetes 3: 293–300.
75. Susanti E, Donosepoetro M, Patellongi I, Arif M (2010). Differences between several atherogenic parameters in patients with Controlled and Uncontrolled Type 2 Diabetes Mellitus. Med J Indones 19: 103–108.
76. Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV (2004). Effect of alpha-lipoic acid on lipid profile in rats fed a high-fructose diet. Exp Diabesity Res 5:195–200.
77. Timmers S, de van Vogel- den Bosch J, Towler MC, Schaart G, Moonen-Kornips E, Mensink RP, et al. (2010). Prevention of high-fat diet-induced muscular lipid accumulation in rats by alpha lipoic acid is not mediated by AMPK activation. J Lipid Res 51:352–359.
78. Wang Y, Li X, Guo Y, Chan L, Guan X (2010). alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice. Metabolism 59: 967–976.
79. Wang L, Wu CG, Fang CQ, Gao J, Liu YZ, Chen Y, et al. (2013). The protective effect of alpha-Lipoic acid on mitochondria in the kidney of diabetic rats. Int J Clin Exp Med 6: 90–97.
80. WHO (2016). Global report on diabete 2016.
81. Yang RL, Li W, Shi YH, Le GW (2008). Lipoic acid prevents high-fat diet-induced dyslipidemia and oxidative stress: a microarray analysis. Nutrition 24: 582–588.
82. Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A (2000). Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43: 294–303.
83. Yi X, Maeda N (2006). Alpha-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet. Diabetes 55: 2238–2244.